🇺🇸 FDA
Pipeline program

HS-10382(Part 1: Dose escalation)

HS-10382-101

Phase 1 small_molecule active

Quick answer

HS-10382(Part 1: Dose escalation) for CML, Chronic Phase is a Phase 1 program (small_molecule) at Jian Li with 1 ClinicalTrials.gov record(s).

Program details

Company
Jian Li
Indication
CML, Chronic Phase
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials